PRESTIGE CONSUMER HEALTHCARE INC. Current Portion of Long-Term Debt
PRESTIGE CONSUMER HEALTHCARE INC. (PBH) had Current Portion of Long-Term Debt of $10.45 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Long-Term Debt and Lease Obligation, Current › Long-Term Debt, Current Maturities
us-gaap:LongTermDebtCurrent · last filed 2026-08-06
- 2026-06-30: Long-term Debt, Current Maturities $10.45M.
- 2026-03-31: Long-term Debt, Current Maturities $0.00.
- 2021-09-30: Long-term Debt, Current Maturities $6.00M.
- 2021-03-31: Long-term Debt, Current Maturities $0.00.
| Period end | Long-term Debt, Current Maturities |
|---|---|
| 2026-06-30 | $10.45M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $0.00 10-Q · filed 2026-08-06 |
| 2021-09-30 | $6.00M 10-Q · filed 2021-11-04 |
| 2021-03-31 | $0.00 10-Q · filed 2021-11-04 |
| 2015-06-30 | $8.53M 10-Q · filed 2015-08-06 |
| 2015-03-31 | $0.00 10-Q · filed 2015-08-06 |
| 2014-09-30 | $7.20M 10-Q · filed 2014-11-06 |
| 2014-03-31 | $0.00 10-Q · filed 2014-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Aurinia Pharmaceuticals Inc. (AUPH) | $2.207B | 7.18 | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 | |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |